Friday, 17 August 2018

Dr. Reddy’s announces launch of Plaquenil generic

11 July 2018 | News

Dr. Reddy’s Hydroxychloroquine Sulfate Tablets are available in 200 mg tablets.

Image credit- consumersreport.org

Image credit- consumersreport.org

Dr. Reddy’s Laboratories Ltd. has announced the launch of Hydroxychloroquine Sulfate Tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil (hydroxychloroquine sulfate) Tablets, in the U.S. market, approved by the U.S. Food and Drug Administration (USFDA).

The Plaquenil brand and generic had U.S. sales of approximately $215 million MAT for the most recent twelve months ending in May 2018 according to IMS Health.

Dr. Reddy’s Hydroxychloroquine Sulfate Tablets are available in 200 mg tablets in the bottle count sizes of 100 and 500.

Plaquenil is a trademark of Concordia International Corp.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Will government's drug price caps trigger showdown with US?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls